Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Uphill

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Microbial Genomics|April 5, 2024
Identifying the best PCR enzyme for library amplification in NGSMichael A Quail, Craig Corton, James Uphill, et al.
Human Mutation|June 14, 2008
Successful amplification of degraded DNA for use with high-throughput SNP genotyping platformsSimon Mead, Mark Poulter, John Beck, et al.
Neurobiology of Aging|August 5, 2015
Inherited mtDNA variations are not strong risk factors in human prion diseaseGavin Hudson, James Uphill, Holger Hummerich, et al.
BMC Medical Genetics|April 9, 2016
Variants of PLCXD3 are not associated with variant or sporadic Creutzfeldt-Jakob disease in a large international studyRubika Balendra, James Uphill, Claire Collinson, et al.
Journal of Neurology|March 10, 2011
A novel exon 2 I27V VCP variant is associated with dissimilar clinical syndromesJonathan D Rohrer, Jason D Warren, David Reiman, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 14, 2008
Genetic susceptibility, evolution and the kuru epidemicSimon Mead, Jerome Whitfield, Mark Poulter, et al.
Plos Genetics|February 14, 2009
HECTD2 is associated with susceptibility to mouse and human prion diseaseSarah E Lloyd, Emma G Maytham, Hirva Pota, et al.
Neurobiology of Aging|March 2, 2015
Rare structural genetic variation in human prion diseasesAna Lukic, James Uphill, Craig A Brown, et al.
The New England Journal of Medicine|November 20, 2009
A novel protective prion protein variant that colocalizes with kuru exposureSimon Mead, Jerome Whitfield, Mark Poulter, et al.
The Lancet. Neurology|December 17, 2008
Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association studySimon Mead, Mark Poulter, James Uphill, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Microbial Genomics|April 5, 2024
Identifying the best PCR enzyme for library amplification in NGSMichael A Quail, Craig Corton, James Uphill, et al.
Human Mutation|June 14, 2008
Successful amplification of degraded DNA for use with high-throughput SNP genotyping platformsSimon Mead, Mark Poulter, John Beck, et al.
Neurobiology of Aging|August 5, 2015
Inherited mtDNA variations are not strong risk factors in human prion diseaseGavin Hudson, James Uphill, Holger Hummerich, et al.
BMC Medical Genetics|April 9, 2016
Variants of PLCXD3 are not associated with variant or sporadic Creutzfeldt-Jakob disease in a large international studyRubika Balendra, James Uphill, Claire Collinson, et al.
Journal of Neurology|March 10, 2011
A novel exon 2 I27V VCP variant is associated with dissimilar clinical syndromesJonathan D Rohrer, Jason D Warren, David Reiman, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 14, 2008
Genetic susceptibility, evolution and the kuru epidemicSimon Mead, Jerome Whitfield, Mark Poulter, et al.
Plos Genetics|February 14, 2009
HECTD2 is associated with susceptibility to mouse and human prion diseaseSarah E Lloyd, Emma G Maytham, Hirva Pota, et al.
Neurobiology of Aging|March 2, 2015
Rare structural genetic variation in human prion diseasesAna Lukic, James Uphill, Craig A Brown, et al.
The New England Journal of Medicine|November 20, 2009
A novel protective prion protein variant that colocalizes with kuru exposureSimon Mead, Jerome Whitfield, Mark Poulter, et al.
The Lancet. Neurology|December 17, 2008
Genetic risk factors for variant Creutzfeldt-Jakob disease: a genome-wide association studySimon Mead, Mark Poulter, James Uphill, et al.
Pageof 3